IL33 and systemic sclerosis: However, a recent study has demonstrated that activated fibroblasts regulate tissue-localized transdifferentiation of regulatory T cells (Tregs) into T helper type 2 cell (Th2)-like cells through IL-33 in SSc lesional skin [2], suggesting that activated dermal fibroblasts amplify an aberrant immune response characteristic of SSc.